Jump to content

25B-NAcPip

Add links
From Wikipedia, the free encyclopedia
25B-NAcPip
Clinical data
Other namesN-(Piperidin-1-ylcarbonylmethyl)-4-bromo-2,5-dimethoxyphenethylamine
ATC code
  • None
Legal status
Legal status
  • In general Unscheduled
Identifiers
  • 2-{[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}-1-(piperidin-1-yl)ethan-1-one
PubChem CID
Chemical and physical data
FormulaC17H25BrN2O3
Molar mass385.302 g·mol−1
3D model (JSmol)
  • COc1cc(Br)c(cc1CCNCC(=O)N1CCCCC1)OC
  • InChI=1S/C17H25BrN2O3/c1-22-15-11-14(18)16(23-2)10-13(15)6-7-19-12-17(21)20-8-4-3-5-9-20/h10-11,19H,3-9,12H2,1-2H3
  • Key:NPHDUYTXALMKMJ-UHFFFAOYSA-N

25B-NAcPip is a chemical compound related to the 25-NB family of psychedelic drugs.[1][2][3] It has been described in patents published by psychedelic pharmaceutical companies like Betterlife Pharma and Mindstate Design Labs.[1][2] Uniquely among 25-NB compounds, 25B-NAcPip is similar to simplified/partial lysergamides and has elements of the chemical structure of LSD and related psychedelic lysergamides like LSD-Pip within its structure.[3] 25B-NAcPip may or may not be a controlled substance in Canada as of 2025.[4]

Chemical structures of 25B-NAcPip and related compounds

See also

[edit]

References

[edit]
  1. ^ a b "Therapeutic combinations, compositions, and methods for designing and producing entactogenic mindstates". Google Patents. 9 March 2023. Retrieved 15 April 2025.
  2. ^ a b "Prevention of drug diversion". Google Patents. 19 April 2022. Retrieved 15 April 2025.
  3. ^ a b "PiHKAL·info". Isomer Design. Retrieved 15 April 2025.
  4. ^ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
[edit]



Stub icon

This hallucinogen-related article is a stub. You can help Wikipedia by adding missing information.

Retrieved from "https://en.wikipedia.org/w/index.php?title=25B-NAcPip&oldid=1338627235"